Avenue Therapeutics, Inc. (ATXI)
0.385
-0.02
(-4.75%)
USD |
OTCM |
Oct 23, 16:00
Avenue Therapeutics Net Income (Quarterly) : -0.69M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.69M |
| March 31, 2026 | -0.695M |
| December 31, 2025 | -0.726M |
| September 30, 2025 | -0.692M |
| June 30, 2025 | 0.329M |
| March 31, 2025 | -1.858M |
| December 31, 2024 | -1.559M |
| September 30, 2024 | -3.087M |
| June 30, 2024 | -7.195M |
| March 31, 2024 | -4.349M |
| December 31, 2023 | 0.617M |
| September 30, 2023 | 0.513M |
| June 30, 2023 | -4.016M |
| March 31, 2023 | -7.602M |
| December 31, 2022 | 0.524M |
| September 30, 2022 | -0.662M |
| June 30, 2022 | -0.604M |
| March 31, 2022 | -2.861M |
| December 31, 2021 | -0.913M |
| Date | Value |
|---|---|
| September 30, 2021 | -0.871M |
| June 30, 2021 | -0.949M |
| March 31, 2021 | -0.998M |
| December 31, 2020 | -0.993M |
| September 30, 2020 | -1.028M |
| June 30, 2020 | -1.888M |
| March 31, 2020 | -1.242M |
| December 31, 2019 | -5.415M |
| September 30, 2019 | -2.242M |
| June 30, 2019 | -6.982M |
| March 31, 2019 | -11.27M |
| December 31, 2018 | -3.919M |
| September 30, 2018 | -2.595M |
| June 30, 2018 | -4.657M |
| March 31, 2018 | -10.38M |
| December 31, 2017 | -6.243M |
| September 30, 2017 | -2.948M |
| June 30, 2017 | -2.406M |
| March 31, 2017 | -0.661M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
| Veru, Inc. | -6.988M |
| Johnson & Johnson | 210.00M |
| Eli Lilly & Co. | 7.095B |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 0.69M |
| EPS Diluted (Quarterly) | -0.2094 |
| Enterprise Value | -0.6734M |
| Earnings Yield | -222.8% |
| Normalized Earnings Yield | -222.78 |